Helyx Industries S.p.A. (BIT:HLX)

Italy flag Italy · Delayed Price · Currency is EUR
0.8240
-0.0080 (-0.96%)
Jun 4, 2026, 3:54 PM CET
Market Cap21.46M +5.9%
Revenue (ttm)1.93M +151.6%
Net Income-4.38M
EPS-0.17
Shares Out 26.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume78,000
Open0.8400
Previous Close0.8320
Day's Range0.7800 - 0.8400
52-Week Range0.5600 - 1.4000
Beta0.69
Analystsn/a
Price Targetn/a
Earnings DateJun 26, 2026

About Helyx Industries

Helyx Industries S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseas... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 22
Stock Exchange Borsa Italiana
Ticker Symbol HLX
Full Company Profile

Financial Performance

In 2025, Helyx Industries's revenue was 1.93 million, an increase of 151.61% compared to the previous year's 767,929. Losses were -4.38 million, -26.32% less than in 2024.

Financial Statements